IPO vs. Acquisition for Life Science Companies: Expert Q&A
Taylor Wirth, Partner at Barnes & Thornburg
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth,…
Continue Reading